Alterations of Gut Microbiota in Pyogenic Liver Abscess Patients with and without Type 2 Diabetes Mellitus

被引:0
|
作者
Liu, Shanshan [1 ,2 ]
Ge, Xiaomeng [3 ]
Xu, Xizhan [4 ]
Zhang, Kang [1 ]
Lu, Xinxin [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, 1 Dongjiaomin Lane, Beijing 100730, Peoples R China
[2] Xuzhou Med Univ, Affiliated Lianyungang Hosp, Peoples Hosp Lianyungang 1, Dept Infect Management, Lianyungang, Jiangsu, Peoples R China
[3] Chinese Acad Sci, Inst Microbiol, Microbial Resources & Big Data Ctr, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr, Beijing, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2024年 / 17卷
关键词
Gut microbiota; Pyogenic liver abscess; type 2 diabetes mellitus; 16S rRNA sequencing; CLINICAL CHARACTERISTICS; EPIDEMIOLOGY; INFECTION; CHINA;
D O I
10.2147/IDR.S456423
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose: The clinical manifestations of pyogenic liver abscess (PLA) vary between patients with and without diabetes mellitus (DM). However, the relationship between PLA and the gut microbiome remains unknown. This study analyzed the composition of gut microbiota in PLA patients with and without DM and healthy controls (HCs) with the goal of identifying potential reasons for the observed variations in clinical manifestations. Patients and Methods: Using 16S ribosomal RNA(16S rRNA) gene sequencing, we analyzed the compositions of gut microbiota in 32 PLA patients with DM, 32 PLA patients without DM, and 29 matched HCs. Results: In PLA patients with DM, the D-dimer level, fibrinogen degradation products, and thrombin time were significantly higher compared to the PLA patients without DM ( P < 0.05). The abundance and diversity of intestinal flora were reduced in both groups of PLA patients compared with the HCs ( P < 0.05). Specifically, the PLA patients with DM showed significant decreases in the relative abundances of Bacteroides, Blautia, Prevotella9 , and Faecalibacterium , whereas Enterococcus and Escherichia-Shigella were relatively more abundant ( P < 0.05). Compared to PLA patients without DM, those with DM had lower relative abundances of Lactobacillus and Klebsiella ( P < 0.05) and showed different bacterial flora, including Anaerosporobacter and Megamonas . Conclusion: PLA patients with DM exhibited more severe clinical manifestations of PLA compared to patients without DM. It is important to monitor blood coagulation in PLA patients with DM to prevent the development of thrombotic diseases. Additionally, PLA patients with DM exhibit distinct differences in the composition and diversity of their intestinal flora compared to both PLA patients without DM and HCs.
引用
收藏
页码:2149 / 2158
页数:10
相关论文
共 50 条
  • [21] Lipidomic signatures linked to gut microbiota alterations in children and adolescents with type 2 diabetes mellitus and metabolic syndrome
    Shirley Mora-Godínez
    Ana Laura de la Garza
    Oscar Tamez-Rivera
    Carolina Senés-Guerrero
    Ana Karen Carrizales-Sánchez
    Gerardo García-Rivas
    Carmen Hernández-Brenes
    Scientific Reports, 15 (1)
  • [22] (-)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and Gut-Liver axis in GK rats
    Zeng, Hongzhe
    Liu, Changwei
    Wan, Liwei
    Peng, Liyuan
    Wen, Shuai
    Fang, Wenwen
    Chen, Hongyu
    Wang, Kuofei
    Yang, Xiaomei
    Huang, Jianan
    Liu, Zhonghua
    FOOD CHEMISTRY, 2024, 447
  • [23] Type-2 Diabetes Mellitus and the Gut Microbiota: Systematic Review
    Slouha, Ethan
    Rezazadah, Atbeen
    Farahbod, Kiana
    Gerts, Andrew
    Clunes, Lucy A.
    Kollias, Theofanis F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [24] Effects of Smoking on the Gut Microbiota in Individuals with Type 2 Diabetes Mellitus
    Kondo, Yuriko
    Hashimoto, Yoshitaka
    Hamaguchi, Masahide
    Kaji, Ayumi
    Sakai, Ryosuke
    Inoue, Ryo
    Kashiwagi, Saori
    Mizushima, Katsura
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Naito, Yuji
    Fukui, Michiaki
    NUTRIENTS, 2022, 14 (22)
  • [25] Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
    Wu, Jiaqiang
    Yang, Kangping
    Fan, Hancheng
    Wei, Meilin
    Xiong, Qin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [26] Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
    Mateus Kawata Salgaço
    Liliane Garcia Segura Oliveira
    Giselle Nobre Costa
    Fernanda Bianchi
    Katia Sivieri
    Applied Microbiology and Biotechnology, 2019, 103 : 9229 - 9238
  • [27] Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus
    Salgaco, Mateus Kawata
    Segura Oliveira, Liliane Garcia
    Costa, Giselle Nobre
    Bianchi, Fernanda
    Sivieri, Katia
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (23-24) : 9229 - 9238
  • [28] Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
    Zhang, Qi
    Hu, Nan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 5003 - 5014
  • [29] Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
    Moreno-Indias, Isabel
    Cardona, Fernando
    Tinahones, Francisco J.
    Isabel Queipo-Ortuno, Maria
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [30] Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia
    Liu, Fengping
    Ling, Zongxin
    Xiao, Yonghong
    Yang, Qing
    Wang, Baohong
    Zheng, Li
    Jiang, Ping
    Li, Lanjuan
    Wang, Wei
    FRONTIERS IN PHYSIOLOGY, 2017, 8